Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer
Clinical trial NCT00193050 · COMPLETED
Trial details
- NCT number
- NCT00193050
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-11-01
- Primary completion
- 2008-03-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.